GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Market Cap

Polaris AI Pharma (XKRX:041910) Market Cap : ₩102,784 Mil (As of May. 30, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Polaris AI Pharma's share price for the quarter that ended in Mar. 2024 was ₩10570. Polaris AI Pharma's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 12 Mil. Therefore, Polaris AI Pharma's market cap for the quarter that ended in Mar. 2024 was ₩123,458 Mil.

Polaris AI Pharma's quarterly market cap increased from Sep. 2023 (₩75,803 Mil) to Dec. 2023 (₩80,592 Mil) and increased from Dec. 2023 (₩80,592 Mil) to Mar. 2024 (₩123,458 Mil).

Polaris AI Pharma's annual market cap declined from Dec. 2021 (₩112,128 Mil) to Dec. 2022 (₩82,811 Mil) and declined from Dec. 2022 (₩82,811 Mil) to Dec. 2023 (₩80,592 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Polaris AI Pharma's Enterprise Value for Today is ₩74,349 Mil.


Polaris AI Pharma Market Cap Historical Data

The historical data trend for Polaris AI Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Market Cap Chart

Polaris AI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122,056.00 147,752.00 112,128.00 82,811.20 80,592.00

Polaris AI Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94,491.20 86,198.40 75,803.20 80,592.00 123,457.60

Competitive Comparison of Polaris AI Pharma's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Polaris AI Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polaris AI Pharma's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Polaris AI Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Polaris AI Pharma's Market Cap falls into.



Polaris AI Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Polaris AI Pharma's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=₩6900*11.68
=₩80,592

Polaris AI Pharma's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₩10570*11.68
=₩123,458

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polaris AI Pharma  (XKRX:041910) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Polaris AI Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Polaris AI Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Polaris AI Pharma (XKRX:041910) Business Description

Traded in Other Exchanges
N/A
Address
1407-9, Hagil-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-938
Estechpharma Co Ltd is engaged in the manufacture and supply of pharmaceutical ingredients and fine chemicals in South Korea.

Polaris AI Pharma (XKRX:041910) Headlines

No Headlines